Highbridge Capital Management LLC Cuts Stake in Quotient Limited (NASDAQ:QTNT)

Highbridge Capital Management LLC lowered its position in shares of Quotient Limited (NASDAQ:QTNT) by 0.2% in the first quarter, Holdings Channel reports. The institutional investor owned 5,321,991 shares of the company’s stock after selling 13,200 shares during the period. Highbridge Capital Management LLC owned 0.05% of Quotient worth $19,585,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently made changes to their positions in QTNT. Sei Investments Co. increased its holdings in shares of Quotient by 1.1% in the 1st quarter. Sei Investments Co. now owns 282,500 shares of the company’s stock valued at $1,040,000 after purchasing an additional 3,195 shares in the last quarter. UBS Group AG increased its holdings in shares of Quotient by 24.5% in the 1st quarter. UBS Group AG now owns 19,784 shares of the company’s stock valued at $73,000 after purchasing an additional 3,898 shares in the last quarter. Artisan Partners Limited Partnership increased its holdings in shares of Quotient by 1.0% in the 1st quarter. Artisan Partners Limited Partnership now owns 3,295,543 shares of the company’s stock valued at $12,128,000 after purchasing an additional 31,934 shares in the last quarter. BlackRock Inc. increased its holdings in shares of Quotient by 11.5% in the 1st quarter. BlackRock Inc. now owns 5,653,344 shares of the company’s stock valued at $20,805,000 after purchasing an additional 583,983 shares in the last quarter. Finally, Swiss National Bank increased its holdings in shares of Quotient by 3.8% in the 1st quarter. Swiss National Bank now owns 184,600 shares of the company’s stock valued at $679,000 after purchasing an additional 6,800 shares in the last quarter. Institutional investors own 80.09% of the company’s stock.

Separately, The Goldman Sachs Group started coverage on shares of Quotient in a report on Thursday, June 3rd. They issued a “neutral” rating and a $5.00 price target for the company.

NASDAQ QTNT traded down $0.06 during trading hours on Friday, reaching $4.34. The company’s stock had a trading volume of 13,432 shares, compared to its average volume of 710,504. The company has a market cap of $440.63 million, a PE ratio of -4.00 and a beta of 2.32. Quotient Limited has a fifty-two week low of $3.41 and a fifty-two week high of $8.77. The business’s 50-day moving average price is $3.96. The company has a debt-to-equity ratio of 17.75, a quick ratio of 2.86 and a current ratio of 3.33.

Quotient (NASDAQ:QTNT) last issued its quarterly earnings data on Monday, May 31st. The company reported ($0.39) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.26) by ($0.13). The business had revenue of $9.64 million during the quarter, compared to analyst estimates of $8.90 million. Quotient had a negative net margin of 223.57% and a negative return on equity of 6,699.81%. As a group, equities research analysts forecast that Quotient Limited will post -1.03 earnings per share for the current year.

About Quotient

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology and serological disease screening.

Further Reading: What is Considered a Good Return on Equity (ROE)?

Want to see what other hedge funds are holding QTNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quotient Limited (NASDAQ:QTNT).

Institutional Ownership by Quarter for Quotient (NASDAQ:QTNT)

Receive News & Ratings for Quotient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quotient and related companies with MarketBeat.com's FREE daily email newsletter.